Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-24-046085

EVP, Chief Development Officer acquired 3,874 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Forbes William P EVP, Chief Development Officer 2024-04-19 Option exercise +3,874 82,874 D
Derivatives
Forbes William P EVP, Chief Development Officer 2024-04-19 Option exercise · Restricted Stock Units −3,874 58,115 D
Loading xslF345X05/ownership.xml…